Monday, April 29, 2024
- Advertisement -spot_img

TAG

Pfizer

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products

Shares of Pfizer are falling ahead of the hole bell as the corporate minimize its full-year outlook, mentioning declining sales of its COVID-19-related productsByMICHELLE...

Pfizer’s Paxlovid still free, for now, after FDA grants full approval to COVID drug

The pharmaceutical corporate, Pfizer, has introduced that the Biden management will proceed to oversee the distribution of loose doses of Pfizer's Paxlovid...

Pfizer seeks another ‘moonshot’ in $43 billion cancer deal with Seagen

Comment in this taleCommentPfizer Inc. stated it could purchase Seagen Inc. for $43 billion in money, a big push into cancer-fighting medication because...

TOP NEWS: GSK welcomes Zantac legal boost in Florida

(Alliance News) - GSK PLC on Tuesday welcomed a US verdict in a lawsuit which had claimed the Zantac heartburn drug brought about most...

Pfizer asks FDA to clear latest vaccination shot for kids under 5

San Francisco units up shot clinics at colleges as winter surge...

RSV Vaccine development: Pfizer shares promising results

The new findings elevate the prospect that a number of vaccines may change into out there earlier than subsequent fall’s RSV season. ...

Pfizer plans to raise price of COVID vaccine

Pfizer might cost up to $130 per dose for its COVID-19 vaccine in 2023, however the photographs will doubtless stay free for folks with...

Pfizer says COVID-19 vaccine will cost up to $130 per dose

The drugmaker stated it expects that individuals with non-public medical health insurance or protection by public applications like Medicare or Medicaid will pay nothing. ...

Latest news

- Advertisement -spot_img